Our organization is a well recognized entity involved in exporting and supplying Crizotinib 200 Mg Capsule. It works as an inhibitor of receptor tyrosine kinase, which is meant for treating non-small cell lung cancer. Specifically, it works by it inhibiting anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteur d'Origine Nantais (RON). Whole range of Crizotinib 200 Mg Capsule is processed under the uidance of our skilled experts by selecting the quality proven range of chemical components and optimum machine in adherence to set quality norms.
Developed and Managed by Infocom Network Private Limited.